EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perilla-Leaf-Derived Extracellular Vesicles Selectively Inhibit Breast Cancer Cell Proliferation and Invasion

Do Kyung Kim, Su Jin Kang, Won Jong Rhee iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Do Kyung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Incheon National University, Research Assistance Program (2021) in the Incheon National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a common type of cancer characterized by high mortality rates. However, chemotherapy is not selective and often leads to side-effects. Therefore, there is a need for the development of highly efficient drugs. Recent studies have shown that some extracellular vesicles (EVs) derived from cell cultures possess anti-cancer activity and hold great potential as cancer therapeutics. However, the use of mammalian cell cultures for EV production results in low productivity and high costs. To address this issue, extracellular vesicles derived from perilla leaves (Perex) were isolated and investigated for their anti-cancer activity in various cancer cells. Initially, a high concentration of Perex with a low level of impurities was successfully purified through a combination of ultrafiltration and size-exclusion chromatography. Perex exhibited potent anti-cancer activities, inhibiting the proliferation, migration, and invasion of MDA-MB-231 cancer cells, which have high levels of caveolin-1 compared to other cancer and normal cells. This selective attack on cancer cells with high levels of caveolin-1 reduces unwanted side-effects on normal cells. Considering its high productivity, low production cost, selective anti-cancer activity, and minimal side-effects, Perex represents a promising candidate for the therapeutic treatment of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsExtracellular VesiclesAnimalsHumansFemaleCaveolin 1Cell Culture TechniquesCell ProliferationCell Line, TumorMammals

Stichwörter der Autor:innen

Perexbreast cancercaveolin-1extracellular vesicleperilla leaf

Substanzen

Caveolin 1

Autor:innen und Institutionen

  • Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
  • Division of Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
  • Research Center for Bio Materials & Process Development, Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon 22012, Republic of Korea.

ORCID-Profile: Won Jong Rhee

Förderung

  • National Research Foundation of Korea
  • Incheon National University
  • Research Assistance Program (2021) in the Incheon National University

Zitieren

APA

Kim, D. K., Kang, S. J., & Rhee, W. J. (2023). Perilla-Leaf-Derived Extracellular Vesicles Selectively Inhibit Breast Cancer Cell Proliferation and Invasion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115633

Vancouver

Kim DK, Kang SJ, Rhee WJ. Perilla-Leaf-Derived Extracellular Vesicles Selectively Inhibit Breast Cancer Cell Proliferation and Invasion. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115633

BibTeX
@article{Kim2023,
  author = {Kim, Do Kyung and Kang, Su Jin and Rhee, Won Jong},
  title = {Perilla-Leaf-Derived Extracellular Vesicles Selectively Inhibit Breast Cancer Cell Proliferation and Invasion},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115633}
}
Kostenlos starten →